These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34662153)

  • 41. Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals.
    Peña M; Ampuero M; Garcés C; Gaggero A; García P; Velasquez MS; Luza R; Alvarez P; Paredes F; Acevedo J; Farfán MJ; Solari S; Soto-Rifo R; Valiente-Echeverría F
    Int J Infect Dis; 2021 Jun; 107():201-204. PubMed ID: 33945868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Asymptomatic COVID-19 Adult Outpatients identified as Significant Viable SARS-CoV-2 Shedders.
    Glenet M; Lebreil AL; Heng L; N'Guyen Y; Meyer I; Andreoletti L
    Sci Rep; 2021 Oct; 11(1):20615. PubMed ID: 34663858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections.
    Stadler RN; Maurer L; Aguilar-Bultet L; Franzeck F; Ruchti C; Kühl R; Widmer AF; Schindler R; Bingisser R; Rentsch KM; Pargger H; Sutter R; Steiner L; Meier C; Kübler W; Hirsch HH; Egli A; Battegay M; Bassetti S; Tschudin-Sutter S
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):44. PubMed ID: 33640031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. No secret hiding place? Absence of SARS-CoV-2 on the ocular surface of 1145 hospitalized patients in a pandemic area.
    Rokohl AC; Grajewski RS; Wawer Matos PA; Koch HL; Dewald F; Klein F; Fätkenheuer G; Lehmann C; Cursiefen C; Heindl LM
    Graefes Arch Clin Exp Ophthalmol; 2021 Jun; 259(6):1605-1608. PubMed ID: 33511435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?
    Gervasi SF; Pengue L; Damato L; Monti R; Pradella S; Pirronti T; Bartoloni A; Epifani F; Saggese A; Cuccaro F; Bianco M; Zeppilli P; Palmieri V
    Br J Sports Med; 2021 Jan; 55(1):54-61. PubMed ID: 33020140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience.
    Meti N; Tahmasebi H; Leahey A; Boudreau A; Thawer A; Stewart J; Reason P; Albright K; Leis JA; Katz K; Cheung MC; Singh S
    Curr Oncol; 2021 Jan; 28(1):278-282. PubMed ID: 33419159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A descriptive analysis of clinical characteristics of COVID-19 among healthcare workers in a district specialist hospital.
    Tan-Loh J; Cheong BMK
    Med J Malaysia; 2021 Jan; 76(1):24-28. PubMed ID: 33510104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ChAdOx1 n-COV 19 Vaccine Protected Health Care Workers From Severe Infection Caused by the Variants.
    Vaishya R; Malani A; Mendiratta L; Butta H; Sibal A; Singh SK; K HP
    Mayo Clin Proc; 2021 Oct; 96(10):2726-2727. PubMed ID: 34479735
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
    Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G
    Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection.
    Harder T; Koch J; Vygen-Bonnet S; Külper-Schiek W; Pilic A; Reda S; Scholz S; Wichmann O
    Euro Surveill; 2021 Sep; 26(35):. PubMed ID: 34477051
    [No Abstract]   [Full Text] [Related]  

  • 53. Implementation, adherence, and results of systematic SARS-CoV-2 testing for asymptomatic patients treated at a tertiary care regional radiation oncology network.
    Prabhu RS; Dhakal R; Hicks AS; McBride J; Patrick AL; Corso CD; Murphy T; Thonen M; Lipford EH; Raghavan D; Burri SH
    Radiat Oncol; 2021 Feb; 16(1):28. PubMed ID: 33541359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The overlooked superpower of mRNA vaccines.
    Wadman M
    Science; 2021 Jul; 373(6554):479. PubMed ID: 34326217
    [No Abstract]   [Full Text] [Related]  

  • 55. SARS-CoV-2 vaccine breakthrough infections among healthcare workers in a large Belgian hospital network.
    Geysels D; Van Damme P; Verstrepen W; Bruynseels P; Janssens B; Smits P; Naesens R
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1755-1757. PubMed ID: 34289927
    [No Abstract]   [Full Text] [Related]  

  • 56. SARS-CoV-2 Detected on Environmental Fomites for Both Asymptomatic and Symptomatic Patients with COVID-19.
    Yang M; Li L; Huang T; Li S; Zhang M; Yang Y; Jiang Y; Li X; Yuan J; Liu Y
    Am J Respir Crit Care Med; 2021 Feb; 203(3):374-378. PubMed ID: 33326364
    [No Abstract]   [Full Text] [Related]  

  • 57. Failure to prescribe: UK workers with occupational long covid-19 have been ignored.
    Watterson A
    BMJ; 2021 Aug; 374():n2018. PubMed ID: 34400406
    [No Abstract]   [Full Text] [Related]  

  • 58. Waves of infection and waves of communication: the importance of sharing in the era of Covid-19.
    Mazzaferro S; Rocca AR; Bagordo D;
    J Nephrol; 2021 Jun; 34(3):633-636. PubMed ID: 33534067
    [No Abstract]   [Full Text] [Related]  

  • 59. COVID-19: Challenging Clinical Questions.
    Laine C; Moyer DV; Cotton D
    Ann Intern Med; 2022 Feb; 175(2):276-277. PubMed ID: 34904908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of death in COVID-19 vaccine breakthrough infections in Brazil.
    Estofolete CF; Fares GF; Banho CA; Sacchetto L; Campos GRF; Moraes MM; Dos Santos TMIL; da Silva GCD; Queiroz F; Mendes LM; Salomão MLM; Negri AF; Barcelos MD; Nogueira ML
    J Infect; 2022 Apr; 84(4):e22-e24. PubMed ID: 35122775
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.